{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:23:43Z","timestamp":1761017023761},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Platelet-rich plasma (PRP) is an autologous platelet concentrate. It is prepared by separating the platelet fraction of whole blood from patients and mixing it with an agent to activate the platelets. In a clinical setting, PRP may be reapplied to the patient to improve and hasten the healing of tissue. The therapeutic effect is based on the presence of growth factors stored in the platelets. Current evidence in orthopedics shows that PRP applications can be used to accelerate bone and soft tissue regeneration following tendon injuries and arthroplasty. Outcomes include decreased inflammation, reduced blood loss and post-treatment pain relief. Recent shoulder research indicates there is poor vascularization present in the area around tendinopathies and this possibly prevents full healing capacity post surgery (<jats:italic>Am J Sports Med<\/jats:italic>\n              <jats:bold>36<\/jats:bold>(6):1171\u20131178, 2008). Although it is becoming popular in other areas of orthopedics there is little evidence regarding the use of PRP for shoulder pathologies. The application of PRP may help to revascularize the area and consequently promote tendon healing. Such evidence highlights an opportunity to explore the efficacy of PRP use during arthroscopic shoulder surgery for rotator cuff pathologies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\/Design<\/jats:title>\n            <jats:p>PARot is a single center, blinded superiority-type randomized controlled trial assessing the clinical outcomes of PRP applications in patients who undergo shoulder surgery for rotator cuff disease. Patients will be randomized to one of the following treatment groups: arthroscopic subacromial decompression surgery or arthroscopic subacromial decompression surgery with application of PRP.<\/jats:p>\n            <jats:p>The study will run for 3\u00a0years and aims to randomize 40 patients. Recruitment will be for 24\u00a0months with final follow-up at 1\u00a0year post surgery. The third year will also involve collation and analysis of the data. This study will be funded through the NIHR Biomedical Research Unit at the Oxford University Hospitals NHS Trust.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Current Controlled Trials: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.controlled-trials.com\/ISRCTN10464365\" ext-link-type=\"uri\">ISRCTN10464365<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1745-6215-14-167","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T04:14:58Z","timestamp":1370924098000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PARot \u2013 assessing platelet-rich plasma plus arthroscopic subacromial decompression in the treatment of rotator cuff tendinopathy: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"14","author":[{"given":"Andrew","family":"Carr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cushla","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Wheway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Rombach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Beard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,11]]},"reference":[{"issue":"3","key":"1337_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/jcp.21368","volume":"215","author":"YMT Kajikawa","year":"2008","unstructured":"Kajikawa YMT, Sakamoto H, Matsuda KI, Oshima Y, Yoshida A, Nagae M, Arai Y, Kawata M, Kubo T: Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiology. 2008, 215 (3): 837-845. 10.1002\/jcp.21368.","journal-title":"J Cell Physiology"},{"key":"1337_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1537-2995.2008.01945.x","volume":"49","author":"MJ Martinez-Zapata","year":"2009","unstructured":"Martinez-Zapata MJ, Marti-Carvajal AM, Sola I, Bolibar I, Exposito JA, Rodriguez L, Garcia J: Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. Transfusion. 2009, 49: 44-56. 10.1111\/j.1537-2995.2008.01945.x.","journal-title":"Transfusion"},{"issue":"4","key":"1337_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0001-2092(06)61320-3","volume":"80","author":"KM Floryan","year":"2004","unstructured":"Floryan KM, Berghoff WJ: Intraooperative use of autologous platelet-rich and platelet-poor plasma for orthopaedic surgery patients. AORN J. 2004, 80 (4): 668-674.","journal-title":"AORN J"},{"key":"1337_CR4","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/bmj.331.7525.1124","volume":"331","author":"C Mitchell","year":"2005","unstructured":"Mitchell C, Adebajo A, Hay E, Carr A: Shoulder pain: diagnosis and management in primary care. BMJ. 2005, 331: 1124-1128. 10.1136\/bmj.331.7525.1124.","journal-title":"BMJ"},{"key":"1337_CR5","volume-title":"Glenohumeral Arthroplasty","author":"CS Neer","year":"1990","unstructured":"Neer CS: Glenohumeral Arthroplasty. 1990"},{"key":"1337_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/ard.57.11.649","volume":"557","author":"M Urwin","year":"1998","unstructured":"Urwin M, Symmons D, Allison T, Brammah T, Busby H, Roxby M, Simmons A, Williams G: Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation. Ann Rheum Dis. 1998, 557: 649-655.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1337_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/art.23330","volume":"59","author":"MAJ Van de Sande","year":"2008","unstructured":"Van de Sande MAJ, De Groot JH, Rozing PM: Clinical implications of rotator cuff degeneration in the rheumatic shoulder. Arthritis Care Res. 2008, 59 (3): 317-324. 10.1002\/art.23330.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"1337_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S1058-2746(99)90148-9","volume":"8","author":"S Tempelhof","year":"1999","unstructured":"Tempelhof S, Rupp S, Seil R: Age-related prevalence of rotator cuff tears in asymptomatic shoulders. J Shoulder Elbow Surg. 1999, 8 (4): 296-299. 10.1016\/S1058-2746(99)90148-9.","journal-title":"J Shoulder Elbow Surg"},{"issue":"1","key":"1337_CR9","first-page":"30","volume":"54","author":"C Lehman","year":"1995","unstructured":"Lehman C, Cuomo F, Kummer JD: The incidence of full thickness rotator cuff tears in a large cadaveric population. Bull Hosp Joint Dis. 1995, 54 (1): 30-31.","journal-title":"Bull Hosp Joint Dis"},{"issue":"6","key":"1337_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1177\/0363546508314430","volume":"36","author":"M De Mos","year":"2008","unstructured":"De Mos M, van der Windt AE, Jahr H, van Schie HTM, Weinans H, Verhaar JAN, van Osch GJVM: Can platelet-rich plasma enhance tendon repair?. Am J Sports Med. 2008, 36 (6): 1171-1178. 10.1177\/0363546508314430.","journal-title":"Am J Sports Med"},{"issue":"1","key":"1337_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00402-007-0549-7","volume":"129","author":"J Dawson","year":"2009","unstructured":"Dawson J: The Oxford shoulder score revisited. Arch Orthop Trauma Surg. 2009, 129 (1): 119-123. 10.1007\/s00402-007-0549-7.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"1337_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1302\/0301-620X.91B1.21058","volume":"91-B","author":"RT Benson","year":"2009","unstructured":"Benson RT: The morphological and immunocytochemical features of impingement syndrome and partial-thickness rotator-cuff tear in relation to outcome after subacromial decompression. J Bone Joint Surg Br. 2009, 91-B (1): 119-123. 10.1302\/0301-620X.91B1.21058.","journal-title":"J Bone Joint Surg Br"},{"key":"1337_CR13","volume-title":"PATH Study Protocol","author":"J Alsousou","year":"2009","unstructured":"Alsousou J: PATH Study Protocol. 2009, University of Oxford"},{"issue":"6","key":"1337_CR14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/BOT.0b013e31817e793f","volume":"22","author":"S Mehta","year":"2008","unstructured":"Mehta S, Watson JT: Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma. 2008, 22 (6): 432-438. 10.1097\/BOT.0b013e31817e793f.","journal-title":"J Orthop Trauma"},{"key":"1337_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.joms.2003.12.003","volume":"62","author":"RE Marx","year":"2004","unstructured":"Marx RE: Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004, 62: 489-496. 10.1016\/j.joms.2003.12.003.","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-14-167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:20:03Z","timestamp":1630542003000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-14-167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,11]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-14-167","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,11]]},"assertion":[{"value":"30 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"167"}}